Injectable cefoperazone sodium and tazobactam sodium ( 6:1 ) in the treatment of moderate to severe acute respiratory bacterial infections:a blind, randomized controlled, multi-center clinical trial

CHEN Feng; YU Hai-ying; MO Bi-wen; SHENG Ji-fang; DING Lian-ming; LI Chong; YIN Qi; LIU Wen-yuan; FU Xiu-hua

doi:10.3969/j.issn.1003-3734.2021.23.012

Home>Articles>Injectable cefoperazone sodium and tazobactam sodium ( 6:1 ) in the treatment of moderate to severe acute respiratory bacterial infections:a blind, randomized controlled, multi-center clinical trial

DOI: 10.3969/j.issn.1003-3734.2021.23.012

Injectable cefoperazone sodium and tazobactam sodium ( 6:1 ) in the treatment of moderate to severe acute respiratory bacterial infections:a blind, randomized controlled, multi-center clinical trial

CHEN Feng

YU Hai-ying

MO Bi-wen

SHENG Ji-fang

DING Lian-ming

LI Chong

YIN Qi

LIU Wen-yuan

FU Xiu-hua

Machine-generated Keywords：

Publication Date：2021-12-15

Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)

Pages：9( 2194-2202 )

Chinese Journal of New Drugs

ISTICPKU

ISSN：1003-3734

Year, Vol.(Issue)：2021,30(23)